On May 20, 2021, Wyand, Michael; Patel, Suman; Swiss, Gerald F. published a patent.Related Products of 130539-43-4 The title of the patent was Low contaminant vaccines against microbes possessing a cell wall structure comprising poly-β-(1→6)-glucosamine (PNAG). And the patent contained the following:
Disclosed are antimicrobial vaccines comprising oligosaccharide β-(1→6)-glucosamine groups linked units onto a tetanus toxoid carrier, wherein less than about 40% of the total number of such units are N-acetylated. The experimental process involved the reaction of Ethyl 2-deoxy-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-1-thio-beta-D-glucopyranoside(cas: 130539-43-4).Related Products of 130539-43-4
The Article related to antimicrobial vaccine cell wall beta glucosamine oligosaccharide, vaccine oligosaccharide beta glucsosamine tetanus toxoid carrier, Pharmaceuticals: Formulation and Compounding and other aspects.Related Products of 130539-43-4
Referemce:
Indole alkaloid derivatives as building blocks of natural products from Bacillus thuringiensis and Bacillus velezensis and their antibacterial and antifungal activity study,
Preparation of Indole Containing Building Blocks for the Regiospecific Construction of Indole Appended Pyrazoles and Pyrroles